Reaction

Intestinal Haemorrhage reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 5,574 reports · 144 co-occurring drugs

As of the last recalculation, Intestinal Haemorrhage appears in 5,574 FAERS reports alongside 144 co-occurring drug terms. The strongest observed disproportionality signal is ISOTRETINOIN (PRR 61.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Isotretinoin	707	61.0	61.9
Insulin Glulisine	44	16.3	16.3
Dabigatran Etexilate	235	11.8	11.8
Dabigatran Etexilate Mesylate	217	11.6	11.6
Nitrofurantoin	47	10.7	10.8
Octreotide Acetate	86	10.6	10.7
Nitrofurantoin (Monohydrate/Macrocrystals)	47	10.6	10.6
Indapamide	48	10.1	10.1
Nintedanib	80	9.7	9.7
Acetaminophen And Codeine	30	9.2	9.3
Thiotepa	20	7.8	7.9
Tretinoin	16	7.4	7.4
Regorafenib	20	6.5	6.5
Clopidogrel Bisulfate	170	6.4	6.4
Ganciclovir	17	6.2	6.2
Ganciclovir Sodium	17	6.0	6.0
Mesalamine	87	5.9	5.9
Prasugrel Hydrochloride	15	5.5	5.5
Iron Sucrose	14	5.5	5.5
Temazepam	52	5.2	5.2
Vedolizumab	116	5.1	5.1
Basiliximab	16	5.1	5.1
Rivaroxaban	267	5.0	5.0
Teduglutide	17	4.7	4.7
Tamsulosin Hydrochloride	25	4.6	4.6
Dimenhydrinate	13	4.6	4.6
Clopidogrel	232	4.5	4.5
Calcium Gluconate	14	4.3	4.4
Donepezil Hydrochloride	41	4.2	4.2
Iron	74	4.2	4.2
Posaconazole	18	4.1	4.2
Dutasteride	9	4.1	4.1
Upadacitinib	89	4.1	4.1
Azathioprine	95	4.1	4.1
Ticagrelor	33	3.9	3.9
Ciclesonide	14	3.8	3.8
Diclofenac	86	3.8	3.8
Anti-Thymocyte Globulin (Rabbit)	8	3.7	3.7
Sucralfate Oral	14	3.7	3.7
Sucralfate Oral Suspension	14	3.7	3.7
Bisoprolol Fumarate	124	3.5	3.5
Adalimumab-Adaz	48	3.4	3.4
Torsemide	30	3.4	3.4
Meropenem	29	3.4	3.4
Indomethacin	12	3.4	3.4
Tranexamic Acid	8	3.4	3.4
Ramipril	108	3.3	3.3
Adalimumab-Aaty	41	3.3	3.3
Ixekizumab	32	3.2	3.2
Daptomycin	8	3.2	3.2
Adalimumab-Fkjp	40	3.2	3.2
Ciprofloxacin Hydrochloride And Hydrocortisone	18	3.2	3.2
Fondaparinux Sodium	7	3.2	3.2
Desloratadine	9	3.1	3.1
Diclofenac Sodium	124	3.1	3.1
Amlodipine Besylate And Valsartan	9	3.0	3.0
Adalimumab	531	3.0	3.0
Riociguat	26	3.0	3.0
Valganciclovir	15	3.0	3.0
Valganciclovir Hydrochloride	15	3.0	3.0
Sucralfate	19	3.0	3.0
Sevelamer Carbonate	9	2.9	2.9
Trazodone Hydrochloride	12	2.9	2.9
Mercaptopurine	13	2.8	2.8
Cholestyramine	9	2.8	2.8
Valsartan And Hydrochlorothiazide	10	2.8	2.8
Allopurinol	113	2.7	2.7
Baricitinib	7	2.7	2.7
Infliximab-Dyyb	21	2.7	2.7
Quetiapine Fumarate	21	2.7	2.7
Encorafenib	7	2.6	2.6
Sunitinib Malate	27	2.6	2.6
Dronedarone	7	2.6	2.6
Infliximab	147	2.6	2.6
Atenolol	88	2.5	2.5
Levodopa	8	2.5	2.5
Valganciclovir Hydrochloride Powder,	8	2.5	2.5
Trifluridine And Tipiracil	7	2.4	2.4
Risankizumab-Rzaa	53	2.4	2.4
Instalax Polyethylene Glycol 3350	8	2.4	2.4
Rivastigmine	12	2.4	2.4
Fludarabine Phosphate	25	2.4	2.4
Busulfan	10	2.4	2.4
Polyethylene Glycol 400	8	2.4	2.4
Desoximetasone	12	2.4	2.4
Warfarin Sodium	29	2.3	2.3
Sorafenib	13	2.3	2.3
Eplerenone	8	2.3	2.3
Naproxen Sodium Tablet	33	2.3	2.3
Metoprolol Tartrate Injection	117	2.3	2.3
Golimumab	53	2.3	2.3
Epoprostenol	8	2.3	2.3
Cetuximab	19	2.3	2.3
Ranolazine	6	2.1	2.1
Secukinumab	91	2.1	2.1
Cortisone Acetate	7	2.1	2.1
Macitentan	39	2.1	2.1
Norepinephrine	6	2.1	2.1
Bosutinib	5	2.1	2.1
Apixaban	37	2.1	2.1
Voriconazole Injection	12	2.1	2.1
Rifampin	8	2.0	2.0
Ibrutinib	44	2.0	2.0
Posaconazole Delayed-Release	6	2.0	2.0
Selexipag	14	2.0	2.0
Linezolid	16	2.0	2.0
Romiplostim	8	2.0	2.0
Tadalafil	52	1.9	1.9
Ibuprofen Sodium	22	1.9	1.9
Tafamidis	6	1.9	1.9
Bosentan	25	1.9	1.9
Blinatumomab	5	1.8	1.8
Ustekinumab	48	1.8	1.8
Orlistat	12	1.7	1.7
Canakinumab	5	1.7	1.7
Trametinib	11	1.7	1.7
Methoxy Polyethylene Glycol-Epoetin Beta	5	1.7	1.7
Capecitabine	40	1.6	1.6
Dasatinib	16	1.6	1.6
Treprostinil	53	1.6	1.6
Cisplatin	33	1.6	1.6
Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride	13	1.6	1.6
Avapritinib	5	1.5	1.5
Acetaminophen, Aspirin (Nsaid) And Caffeine	7	1.5	1.5
Emicizumab	5	1.5	1.5
Azacitidine	12	1.5	1.5
Lenvatinib	13	1.5	1.5
Docetaxel Anhydrous	26	1.4	1.4
Docetaxel	26	1.4	1.4
Azacitidine For	7	1.4	1.4
Dabrafenib	8	1.4	1.4
Pemetrexed	8	1.4	1.4
Ambrisentan	44	1.3	1.3
Diroximel Fumarate	4	1.3	1.3
Acetaminophen, Aspirin, And Caffeine	7	1.2	1.2
Ruxolitinib	23	1.2	1.2
Palbociclib	30	1.2	1.2
Peginterferon Beta-1A	4	1.1	1.1
Pazopanib Hydrochloride	8	1.1	1.1
Leuprolide Acetate	22	1.1	1.1
Apremilast	38	1.0	1.0
Abiraterone Acetate	10	0.9	0.9
Enzalutamide	13	0.8	0.8
Adapalene	4	0.1	0.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.